Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Evolution and Management of Migraine Recurrence Beyond 24 Hours

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Endo Pharmaceuticals
Information provided by:
Rutgers, The State University of New Jersey
ClinicalTrials.gov Identifier:
NCT00754611
First received: September 9, 2008
Last updated: February 3, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2010
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)